# Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis

> **NCT05662059** · NA · UNKNOWN · sponsor: **Cala Health, Inc.** · enrollment: 30 (estimated)

## Conditions studied

- Ulcerative Colitis

## Interventions

- **DEVICE:** RAVANS
- **DEVICE:** RAVANS-sham

## Key facts

- **NCT ID:** NCT05662059
- **Lead sponsor:** Cala Health, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-01-12
- **Primary completion:** 2023-12-30
- **Final completion:** 2023-12-30
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2023-03-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05662059

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05662059, "Respiratory-gated Auricular Vagal Afferent Nerve Stimulation (RAVANS) Study in Ulcerative Colitis". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT05662059. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*